Contact PD/PI: CRONSTEIN, BRUCE Neil OVERALL PROJECT SUMMARY Increasingly, the effective translation of groundbreaking biomedical discoveries and successful adoption of evidence-based therapies and interventions aimed to improve population health and reduce health disparities requires the coordinated efforts of multi-disciplinary and multi-sectoral partnerships with diverse expertise, interests, and skills. The New York University (NYU)-Health and Hospitals Corporation (HHC) Clinical and Translational Science Institute (CTSI) represents an innovative public-private research partnership designed to foster clinical and translational research and transform the delivery of care in clinical and community practice. With this application, we have assembled a partnership of institutions with unique and complementary strengths: a private research university with a history of public service and substantial biomedical, behavioral, and population health expertise (NYU), the largest municipal healthcare system in the United States (HHC), a state psychiatric institute (Nathan Kline Institute), and various community organizations that represent the rich diversity of populations in NYC. As the centralized hub, our CTSI catalyzes research and facilitates access to essential core services, resources, and expertise necessary to engage in the full spectrum of clinical and translational research across our partner institutions. Moreover, the CTSI serves as a nexus for collaboration between investigators at our partner institutions and the nationwide network of CTSA hubs. We will build on our success in markedly expanding clinical and translational research at our hub and an established history of research collaboration between NYU and HHC to further accelerate the pace and impact of discovery, development, validation, and implementation across the full spectrum of translational research. To accomplish this goal, we propose an array of innovative and evidence-based strategies delineated in our application, all within the framework of six overarching Specific Aims. 1) Catalyze and support innovative, collaborative translational research that improves health across the lifespan in our diverse communities. 2) Ensure the quality, safety, and efficiency of local clinical and translational research and to disseminate successful approaches. 3) Stimulate, support, and disseminate innovative methods in the clinical and translational sciences. 4) Foster community-engaged collaborative and team-based science among our diverse community of investigators and stakeholders, rich array of partner institutions, and the national CTSA network. 5) Educate, train, and cultivate the next generation of the translational research workforce. 6) Integrate our clinical, education, and research missions and operations to foster a learning healthcare system. Project Summary/Abstract Page 201 Contact PD/PI: CRONSTEIN, BRUCE Neil OVERALL

Public Health Relevance

The New York University (NYU) ? NYC Health and Hospitals Corporation (HHC) Clinical and Translational Science Institute (CTSI) is a central hub that supports the full range of health-related research at the largest private university in the United States and its partner institutions, HHC, the largest municipal healthcare system in the country, Nathan Kline Institute (NKI), a New York State psychiatric institute, and our partner organizations in our highly diverse community. The CTSI also interfaces with the national CTSA consortium to support broader clinical and translational research endeavors. Project Narrative Page 202

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
1UL1TR001445-01
Application #
9085750
Study Section
Special Emphasis Panel (ZTR1-SRC (99))
Program Officer
Talbot, Bernard
Project Start
2015-08-18
Project End
2020-03-31
Budget Start
2015-08-18
Budget End
2016-03-31
Support Year
1
Fiscal Year
2015
Total Cost
$4,894,106
Indirect Cost
$1,863,678
Name
New York University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Haskó, György; Antonioli, Luca; Cronstein, Bruce N (2018) Adenosine metabolism, immunity and joint health. Biochem Pharmacol 151:307-313
Weisleder, Adriana; Mazzuchelli, Denise S R; Lopez, Aline Sá et al. (2018) Reading Aloud and Child Development: A Cluster-Randomized Trial in Brazil. Pediatrics 141:
Wu, Benjamin G; Segal, Leopoldo N (2018) The Lung Microbiome and Its Role in Pneumonia. Clin Chest Med 39:677-689
Fruchter, Renee; Ahmad, Meleha; Pillinger, Michael et al. (2018) Teaching Targeted Drug Discovery and Development to Healthcare Professionals. Clin Transl Sci 11:277-282
Slobodnick, Anastasia; Shah, Binita; Krasnokutsky, Svetlana et al. (2018) Update on colchicine, 2017. Rheumatology (Oxford) 57:i4-i11
Tsay, Jun-Chieh J; Wu, Benjamin G; Badri, Michelle H et al. (2018) Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer. Am J Respir Crit Care Med 198:1188-1198
Ursua, Rhodora A; Aguilar, David E; Wyatt, Laura C et al. (2018) A community health worker intervention to improve blood pressure among Filipino Americans with hypertension: A randomized controlled trial. Prev Med Rep 11:42-48
Patibandla, Jay R; Fehniger, Julia E; Levine, Douglas A et al. (2018) Small cell cancers of the female genital tract: Molecular and clinical aspects. Gynecol Oncol 149:420-427
Pelzek, Adam J; Shopsin, Bo; Radke, Emily E et al. (2018) Human Memory B Cells Targeting Staphylococcus aureus Exotoxins Are Prevalent with Skin and Soft Tissue Infection. MBio 9:
Aoki, Chiye; Chen, Yi-Wen; Chowdhury, Tara Gunkali et al. (2018) ?4??-GABAA receptors in dorsal hippocampal CA1 of adolescent female rats traffic to the plasma membrane of dendritic spines following voluntary exercise and contribute to protection of animals from activity-based anorexia through localization at excitator J Neurosci Res 96:1450-1466

Showing the most recent 10 out of 278 publications